Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

  • Morcillo, Miguel Ángel
  • García de Lucas, Ángel
  • Oteo, Marta
  • Romero, Eduardo
  • Magro, Natalia
  • Ibáñez, Marta
  • Martínez, Alfonso
  • Garaulet, Guillermo
  • Arroyo, Alicia G
  • Lopez Casas, Pedro Pablo
  • Hidalgo, Manuel
  • Mulero, Francisca
  • Martinez Torrecuadrada, Jorge Luis
Pancreatic ductal adenocarcinoma (PDAC) continues to be one of the deadliest cancers for which optimal diagnostic tools are still greatly needed. Identification of PDAC-specific molecular markers would be extremely useful to improve disease diagnosis and follow-up. MT1-MMP has long been involved in pancreatic cancer, especially in tumour invasion and metastasis. In this study, we aim to ascertain the suitability of MT1-MMP as a biomarker for positron emission tomography (PET) imaging. Two probes were assessed and compared for this purpose, an MT1-MMP-specific binding peptide (MT1-AF7p) and a specific antibody (LEM2/15), labelled, respectively, with 68Ga and with 89Zr. PET imaging with both probes was conducted in patient-derived xenograft (PDX), subcutaneous and orthotopic, PDAC mouse models, and in a cancer cell line (CAPAN-2)-derived xenograft (CDX) model. Both radiolabelled tracers were successful in identifying, by means of PET imaging techniques, tumour tissues expressing MT1-MMP although they did so at different uptake levels. The 89Zr-DFO-LEM2/15 probe showed greater specific activity compared to the 68Ga-labelled peptide. The mean value of tumour uptake for the 89Zr-DFO-LEM2/15 probe (5.67 ± 1.11%ID/g, n=28) was 25-30 times higher than that of the 68Ga-DOTA-AF7p ones. Tumour/blood ratios (1.13 ± 0.51 and 1.44 ± 0.43 at 5 and 7 days of 89Zr-DFO-LEM2/15 after injection) were higher than those estimated for 68Ga-DOTA-AF7p probes (of approximately tumour/blood ratio = 0.5 at 90 min after injection). Our findings strongly point out that (i) the in vivo detection of MT1-MMP by PET imaging is a promising strategy for PDAC diagnosis and (ii) labelled LEM2/15 antibody is a better candidate than MT1-AF7p for PDAC detection.
Repisalud
Publicación Artículo científico (JournalArticle)

Coronary microcirculation damage in anthracycline cardiotoxicity.

  • Galan-Arriola, Carlos
  • Vilchez-Tschischke, Jean Paul
  • Lobo, Manuel
  • Lopez, Gonzalo Javier
  • Molina-Iracheta, Antonio
  • Pérez-Martínez, Claudia
  • Villena-Gutierrez, Rocio
  • Macias, Alvaro
  • Díaz-Rengifo, Iván A
  • Oliver, Eduardo
  • Fuster, Valentin
  • Sanchez-Gonzalez, Javier
  • Ibáñez, Borja
The aim of this study was to study changes in coronary microcirculation status during and after several cycles of anthracycline treatment. Large-White male pigs (n = 40) were included in different experimental protocols (ExPr.) according to anthracycline cumulative exposure (0.45 mg/kg intracoronary (IC) doxorubicin per injection) and follow-up: Control (no doxorubicin); Single injection and sacrifice either at 48 hours (ExPr. 1) or 2 weeks (ExPr. 2); Three injections two weeks apart (low cumulative dose) and sacrifice either 2 weeks (ExPr. 3) or 12 weeks (ExPr. 4) after third injection; Five injections two weeks apart (high cumulative dose) and sacrifice 8 weeks after fifth injection (ExPr. 5). All groups were assessed by serial cardiac magnetic resonance (CMR) to quantify perfusion and invasive measurement of coronary flow reserve (CFR). At the end of each protocol, animals were sacrificed for ex vivo analyses. Vascular function was further evaluated by myography in explanted coronary arteries of pigs undergoing ExPr. 3 and controls.A single doxorubicin injection had no impact on microcirculation status, excluding a direct chemical toxicity. A series of five fortnightly doxorubicin injections (high cumulative dose) triggered a progressive decline in microcirculation status, evidenced by reduced CMR-based myocardial perfusion and CFR-measured impaired functional microcirculation. In the high cumulative dose regime (ExPr. 5), microcirculation changes appeared long before any contractile defect became apparent. Low cumulative doxorubicin dose (3 biweekly injections) was not associated with any contractile defect across long-term follow-up, but provoked persistent microcirculation damage, evident soon after third dose injection. Histological and myograph evaluations confirmed structural damage to arteries of all calibers even in animals undergoing low cumulative dose regimes. Conversely, arteriole damage and capillary bed alteration occurred only after high cumulative dose regime. Serial in vivo evaluations of microcirculation status using state-of-the-art CMR and invasive CFR show that anthracyclines treatment is associated with progressive and irreversible damage to the microcirculation. This long-persisting damage is present even in low cumulative dose regimes, which are not associated with cardiac contractile deficits. Microcirculation damage might explain some of the increased incidence of cardiovascular events in cancer survivors who received anthracyclines without showing cardiac contractile defects.
Repisalud
Publicación Artículo científico (JournalArticle)

Association Between Left Ventricular Noncompaction and Vigorous Physical Activity.

  • de la Chica, Jose A
  • Gomez-Talavera, Sandra
  • Garcia-Ruiz, Jose M
  • Garcia-Lunar, Ines
  • Oliva, Belen
  • Fernandez-Alvira, Juan Miguel
  • Lopez-Melgar, Beatriz
  • Sanchez-Gonzalez, Javier
  • de la Pompa, Jose Luis
  • Mendiguren, Jose M
  • Martínez de Vega, Vicente
  • Fernandez-Ortiz, Antonio
  • Sanz, Javier
  • Fernandez-Friera, Leticia
  • Ibáñez, Borja
  • Fuster, Valentin
Left ventricular (LV) hypertrabeculation fulfilling noncompaction cardiomyopathy criteria has been detected in athletes. However, the association between LV noncompaction (LVNC) phenotype and vigorous physical activity (VPA) in the general population is disputed. The aim of this study was to assess the relationship between LVNC phenotype on cardiac magnetic resonance (CMR) imaging and accelerometer-measured physical activity (PA) in a cohort of middle-aged nonathlete participants in the PESA (Progression of Early Subclinical Atherosclerosis) study. In PESA participants (n = 4,184 subjects free of cardiovascular disease), PA was measured by waist-secured accelerometers. CMR was performed in 705 subjects (mean age 48 ± 4 years, 16% women). VPA was recorded as total minutes per week. The study population was divided into 6 groups: no VPA and 5 sex-specific quintiles of VPA rate (Q1 to Q5). The Petersen criterion for LVNC was evaluated in all subjects undergoing CMR. For participants meeting this criterion (noncompacted-to-compacted ratio ≥2.3), 3 more restrictive LVNC criteria were also evaluated (Jacquier, Grothoff, and Stacey). LVNC phenotype prevalence according to the Petersen criterion was significantly higher among participants in the highest VPA quintile (Q5 = 30.5%) than in participants with no VPA (14.2%). The Jacquier and Grothoff criteria were also more frequently fulfilled in participants in the highest VPA quintile (Jacquier Q5 = 27.4% vs. no VPA = 12.8% and Grothoff Q5 = 15.8% vs. no VPA = 7.1%). The prevalence of the systolic Stacey LVNC criterion was low (3.6%) and did not differ significantly between no VPA and Q5. In a community-based study, VPA was associated with a higher prevalence of CMR-detected LVNC phenotype according to diverse established criteria. The association between VPA and LVNC phenotype was independent of LV volumes. According to these data, vigorous recreational PA should be considered as a possible but not uncommon determinant of LV hypertrabeculation in asymptomatic subjects.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Upconverting Nanoparticles in Aqueous Media: Not a Dead-End Road. Avoiding Degradation by Using Hydrophobic Polymer Shells

  • Méndez-González, Diego
  • Torres Vera, Vivian
  • Zabala Gutiérrez, Irene
  • Gerke, Christoph
  • Cascales, Concepción
  • Rubio-Retama, Jorge
  • Calderón, Oscar G.
  • Melle, Sonia
  • Laurenti, Marco
The stunning optical properties of upconverting nanoparticles (UCNPs) have inspired promising biomedical technologies. Nevertheless, their transfer to aqueous media is often accompanied by intense luminescence quenching, partial dissolution by water, and even complete degradation by molecules such as phosphates. Currently, these are major issues hampering the translation of UCNPs to the clinic. In this work, a strategy is developed to coat and protect β-NaYF4 UCNPs against these effects, by growing a hydrophobic polymer shell (HPS) through miniemulsion polymerization of styrene (St), or St and methyl methacrylate mixtures. This allows one to obtain single core@shell UCNPs@HPS with a final diameter of ≈60–70 nm. Stability studies reveal that these HPSs serve as a very effective barrier, impeding polar molecules to affect UCNPs optical properties. Even more, it allows UCNPs to withstand aggressive conditions such as high dilutions (5 µg mL−1), high phosphate concentrations (100 mm), and high temperatures (70 °C). The physicochemical characterizations prove the potential of HPSs to overcome the current limitations of UCNPs. This strategy, which can be applied to other nanomaterials with similar limitations, paves the way toward more stable and reliable UCNPs with applications in life sciences. © 2021 Wiley-VCH GmbH., This work has been founded by the Ministerio de EconomÍa y Competitividad-MINECO (MAT2017-83111R), Ministerio de Ciencia, Innovación y Universidades-MICIU (RTI2018-094859-B-I00), Ministerio de Ciencia, Innovación y Universidades (PID2019-106211RB-I00; “NANONERV”), and by the Comunidad de Madrid (B2017/BMD- 3867 RENIM-CM) cofinanced by European Structural and Investment Fund. D.M.-G. acknowledges UCM-Santander for a postdoctoral orientation period contract (CT17/17-CT18/17) and the Fundación para la investigación biomédica del Hospital Ramón y Cajal (FIBioHRyC), the Instituto Ramón y Cajal de Investigación Sanitaria (IRyCIS), and the European Commission Horizon 2020 project NanoTBTech (grant number: 801305) for postdoctoral funding. I.Z.G. thanks UCM-Santander for a predoctoral contract (CT63/19-CT64/19). V.T.V. thanks Colfuturo and the Colombian government for a predoctoral scholarship. C.G. gratefully acknowledges the European Commission for the financial support through a Marie Skłodowska-Curie Action – Individual Fellowship (SPOT Action with Grant agreement ID 895932). The authors thank the staff at the ICTS-National Centre for Electron Microscopy (CNME) at the UCM and SCAI (UMA) for the help in the electron microscopy studies., No